Tricarboxylic acids and derivatives
Medchemexpress LLC Adenosine 5'-(α,β-methylene)diphosphate triammonium | 00-00-0 | MFCD00042991 | 99.9% | 476.32 g·mol⁻¹ | C11H26N8O9P2 | 5 MG
MethADP triammonium (Adenosine 5'-(α,β-methylene)diphosphate triammonium) is a nucleotide analog used as a selective CD73 inhibitor for research into the ATP-adenosine pathway. Supplied as the triammonium salt, it is provided for laboratory research use in solid or solution form.
- CD73 inhibitor for ATP-adenosine pathway studies.
- High purity: 99.9%.
- Molecular weight 476.32 g·mol⁻¹; chemical formula C11H26N8O9P2.
- Appearance: off-white to light yellow solid.
- Storage: solid at 4°C; in solvent -80°C up to 6 months, -20°C up to 1 month.
- Available in small solid quantities and as a 10 mM solution.
Selleck Chemical LLC Sodium mesoxalate monohydrate S2992-100mg
Sodium mesoxalate monohydrate (sodium 2 2-dihydroxymalonate) is an endogenous metabolite
Apexbio Technology LLC Lithium Citrate,100g CAS# 6080-58-6
Lithium Citrate is the active component of Lithium which is a drug used in treatment of psychiatric disease [1].Lithium Citrate has shown the effects on metabolic and signaling pathways in the brain based on the specific clinical condition and disease model [2]. Lithium Citrate has been reported to use as a mood stabilizer when treating bipolar mood disorders (BD) and reduce the risk of self-harm in BD patient. In addition, Lithium Citrate has been found to be the choice drug in treatment of acute manic episodes. Moreover, Lithium Citrate has been revealed to dissolve uric acid crystals in urine obtained from patients with gout. Besides, Lithium Citrate has been exhibited to have some dose-dependent side-effects. The most of the side-effects of Lithium Citrate is the tendency to inhibit the prostatic acid phosphatase enzyme (PAP), which leading to the accumulation of PAP [1]. Other sizes are also available. Please inqury us for quote.
Medchemexpress LLC m-PEG8-CH2COOH | 102013-72-9 | 99.9% | 250 MG
m-PEG8-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
- PEG-based PROTAC linker
- Used in the synthesis of PROTACs
Medchemexpress LLC Tos-PEG3-CH2COOH | 1581248-63-6 | 25 MG
Tos-PEG3-CH2COOH is a PEG-based PROTAC linker. It can be used in the synthesis of PROTACs, which are compounds designed to exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. PROTACs typically contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein.
- PEG-based linker for PROTAC synthesis
- Utilizes the ubiquitin-proteasome system
- Designed to selectively degrade target proteins
- Composed of two ligands connected by a linker
Medchemexpress LLC Mangafodipir trisodium | 140678-14-4 | 99.7% | 5 MG
Mangafodipir trisodium (MnDPDP) is a hepatocellular-specific contrast agent and an efficacious inhibitor of chemotherapy-induced peripheral neuropathy (CIPN) and other conditions caused by cellular oxidative stress. It shows no negative interference with the tumoricidal activity of chemotherapy.
- Hepatocellular-specific contrast agent
- Efficacious inhibitor of chemotherapy-induced peripheral neuropathy
- Attenuates apoptosis caused by cisplatin in HGrC cells
- Protects against ovarian damage caused by cisplatin and paclitaxel in mice
![eMolecules 68-04-2 | Sodium citrate, anhydrous | Oakwood Chemical | MFCD00012462 | 258.068 | C6H5Na3O7 | 99.000 | [Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O | 25g | 866847505](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000470643.jpg-250.jpg)
eMolecules 68-04-2 | Sodium citrate, anhydrous | Oakwood Chemical | MFCD00012462 | 258.068 | C6H5Na3O7 | 99.000 | [Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O | 25g | 866847505
Sodium citrate, anhydrous | Oakwood Chemical | 68-04-2 | MFCD00012462 | 258.068 | C6H5Na3O7 | 99.000 | [Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O | 25g | 866847505
Selleck Chemical LLC Amfenac Sodium Monohydrate S4149-1g
Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety The IC50 values for COX1 and COX2 is 250 nM and 150 nM respectively
Medchemexpress LLC Oxeladin citrate | 52432-72-1 | 98.0% | 1 ML
Oxeladin citrate is an orally active and brain-penetrant cough suppressant. It acts as a selective sigma 1 receptor agonist with a Ki of 25 nM, and has potential applications in pulmonary diseases and stroke research.
- Orally active and brain-penetrant cough suppressant
- Selective sigma 1 receptor agonist
- Used for pulmonary diseases and stroke research
- Facilitates S1R mediated brain-derived neurotrophic factor secretion
- Reduces infarct expansion in subacute phase of stroke
- Improves neurological function
Medchemexpress LLC IACS-8803 diammonium | 00-00-0 | 96.7% | C20H29FN12O9P2S2 | 10MG
IACS-8803 (diammonium) is a cyclic dinucleotide STING agonist supplied as a diammonium salt for research use. It potently activates the STING pathway and has demonstrated robust systemic antitumor efficacy in preclinical studies. The diammonium salt improves handling and stability compared with the free form and is intended for in vitro and in vivo immuno-oncology research.
- Potent STING pathway agonist for immune activation.
- Demonstrated systemic antitumor efficacy in preclinical models.
- Suitable for in vitro and in vivo research applications.
- Diammonium salt formulation for improved stability and handling.
- Requires cold-chain storage; research use only.
Medchemexpress LLC Triammonium phosphate trihydrate | 25447-33-0 | MFCD00151223 | ≥98.0% | 203.13 | H18N3O7P | 100g
Triammonium phosphate trihydrate interacts with the magnesium ions to form a precipitate which can be used for magnesium separation from lithium in salt-lake brines[1]
Medchemexpress LLC Citrate synthase | 9027-96-7 | ~98 KDa dimer (49 KDa monomer) | 1000 U
Citrate synthase catalyzes the initial reaction of the citric acid cycle, facilitating the condensation of acetyl-CoA and oxaloacetate to produce citrate. This enzyme is primarily found within the mitochondrial matrix of eukaryotic cells.
- Catalyzes the condensation of acetyl-CoA and oxaloacetate
- Forms citrate, initiating the citric acid cycle
- Localized in the mitochondrial matrix of eukaryotic cells
- Specific activity of ≥100 U/mg protein
- Unit defined as 1.0 μmole of citrate formed per minute at pH 8.0 at 37°C
- Liquid appearance
- Colorless to light yellow
- Molecular weight of ~98 KDa dimer (49 KDa monomer)
Medchemexpress LLC Butamirate citrate | 18109-81-4 | MFCD00315222 | 99.9% | 499.6 g/mol | C24H37NO10 | 5 MG
Butamirate citrate is an orally active antitussive research compound supplied as the citrate salt. It acts centrally to suppress cough and has reported bronchodilatory and anti-inflammatory effects. Provided as a high-purity analytical standard for research use only.
- Orally active antitussive agent suitable for research.
- High purity analytical standard for assay and method development.
- Reported bronchodilatory and anti-inflammatory properties.
- Available in small packaged quantities for laboratory use.
- For research use only; not for human or clinical use.